The Systems and Processes in the Life Sciences industry that have been used to manage quality are now inadequate. With current complexity across the market, manufactures require to adapt and change their strategy to create market differentiation and improve operational and financial performance. Digitalization across business and operational systems will help manufactures to control quality and to achieve unprecedented insights and performance.
This research report addresses life sciences challenges and how market leaders approach them today. Specifically, it examines:
- How rising world populations and standards of living increase spending on healthcare
- Pressures from the US FDA and other regulatory bodies to satisfy cGMP regulations and quality expectations
- Why a shift from traditional quality is necessary to address new expectations and improve corporate success